SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (Nasdaq:AFFX) wishes to issue the following update to its release BW5349 (CA-AFFYMETRIX) “Affymetrix to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference” issued Thursday, February 1, 2007:
